Zurich/Zug – SkyCell has closed a Series D financing round in the amount of 116 million dollars. These funds will be used to expand SkyCell’s global presence. Two new investors are significantly expanding Skycell’s presence in the USA and Asia.
SkyCell, headquartered in Zug and Technopark Zurich, has received 116 million dollars in fresh capital in a Series D financing round. According to a statement, these funds will be used to expand the company's global presence. SkyCell intends to focus on growing its temperature-controlled door-to-door air freight containers for sensitive pharmaceutical products in North and South America, EMEA and Asia.
This expansion will be facilitated by the two new investors. Tybourne Capital, headquartered in Hong Kong, manages long-term capital on behalf of prominent charitable organizations, foundations and pension funds. CCI, a Chicago-based subsidiary of Henry Crown and Company, invests in growth companies that focus on environmental sustainability.
"Having established the technological foundations in cold chain hardware and software/IoT-enabled tracking, this investment enables us to commercialize our platform in adjacent pharma market segments, significantly expanding our total addressable market beyond cold chain packaging," Skycell CFO Dr. Remo Gerber is quoted as saying.
According to CEO and co-founder Richard Ettl, the latest reusable container saves an average of 50 percent CO2, or 8 tons of CO2 per use in absolute terms. And finally, digitalization is finding its way into the pharmaceutical supply chains. "Combined with the power of AI, this enables our customers to significantly reduce costs and risks. With this new investment, we can further optimize supply chains and create truly sustainable logistics." ce/mm